Online Only Articles

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes;Department of Nuclear Medicine, CHU Nantes, Nantes
CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes;Department of Nuclear Medicine, CHU Nantes, Nantes
Department of Nuclear Medicine, CLCC Georges François Leclerc
Department of Hematology, CHU Dijon Bourgogne, Dijon
Department of Hematology, CHU Tours, Tours
LYSA Imaging, Creteil
Department of Pathology, CHU Nantes, Nantes
Department of Pathology, CHU Paris Hôpital Cochin, Paris
Department of Nuclear Medicine, CHU Grenoble-Alpes, Grenoble
Onco Hematology Department, Hospital University Grenoble, La Tronche, Grenoble
Department of Nuclear Medicine, CLCC Eugene Marquis
Department of Hematology, CHU Rennes;Inserm U1236, University of Rennes, Rennes
Onco Hematology Department, CHU Paris-GH St-Louis Lariboisière
Department of Hematology, CHU Paris - Hôpital Necker-Enfants Malades, Paris
CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes;Department of Nuclear Medicine, CHU Nantes, Nantes;Department of Nuclear Medicine, ICO-René Gauducheau, Saint-Herblain
CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes;Department of Hematology, CHU Nantes, Nantes, France
CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes;Department of Nuclear Medicine, CHU Nantes, Nantes
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2019.223016